ConjuChem: Clinical Trials

4 trials sponsored by ConjuChem, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Terminated 2

Follow ConjuChem: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
CJC-1134-PC Injection, Weekly placebo for CJC-1134-PC Injection - Type 2 Diabetes Mellitus (T2DM)
Phase 2TerminatedConjuChem732011-09-012017-07-19
A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy
1.5 mg or 2.0 mg CJC-1134-PC, Placebo - Type 2 Diabetes Mellitus
Phase 2CompletedConjuChem902008-03-012017-06-02
A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy
CJC-1134-PC, Placebo - Type 2 Diabetes Mellitus
Phase 2CompletedConjuChem1222008-02-012017-06-02
A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity
CJC 1295 - Obesity, HIV Infections
Phase 2TerminatedConjuChem1202005-12-012006-10-16

Conditions studied

Diabetes Mellitus, Type 2 (3)  ·  Diabetes Mellitus (1)  ·  HIV Infections (1)  ·  Obesity (1)

Interventions

CJC 1295 (1)  ·  Metformin (1)

Countries

Canada (3)  ·  United States (1)

Top investigators

Maggie Wang, MD (1)  ·  Patrick Soon-Shiong, MD (1)  ·  Robert Henry, MD (1)